• Product name

    Anti-EKLF / KLF1 antibody - ChIP Grade
    See all EKLF / KLF1 primary antibodies
  • Description

    Goat polyclonal to EKLF / KLF1 - ChIP Grade
  • Host species

  • Tested applications

    Suitable for: ChIP, WBmore details
  • Species reactivity

    Reacts with: Mouse, Human
    Predicted to work with: Cow, Dog, Pig
  • Immunogen

    Synthetic peptide:


    , corresponding to N terminal amino acids 2-15 of Human KLF1.



Our Abpromise guarantee covers the use of ab2483 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ChIP Use at an assay dependent dilution. PubMed: 19074263
WB Use at an assay dependent dilution. Preliminary experiments gave an approx 52kDa band in K562 cell lysate after 1ug/ml antibody staining. Please note that currently we cannot find an explanation in the literature for the band we observe given the predicted size of 38kDa according to NP_006554. The 52kDa band was successfully blocked by incubation with the immunizing peptide


  • Function

    Transcription regulator of erythrocyte development that probably serves as a general switch factor during erythropoiesis. Is a dual regulator of fetal-to-adult globin switching. Binds to the CACCC box in the beta-globin gene promoter and acts as a preferential activator of this gene. Furthermore, it binds to the BCL11A promoter and activates expression of BCL11A, which in turn represses the HBG1 and HBG2 genes. This dual activity ensures that, in most adults, fetal hemoglobin levels are low. Able to activate CD44 and AQP1 promoters. When sumoylated, acts as a transcriptional repressor by promoting interaction with CDH2/MI2beta and also represses megakaryocytic differentiation.
  • Tissue specificity

    Expression restricted to adult bone marrow and fetal liver. Not expressed in myeloid nor lymphoid cell lines.
  • Involvement in disease

    Defects in KLF1 are the cause of congenital dyserythropoietic anemia type 4 (CDA4) [MIM:613673]. It is a blood disorder characterized by ineffective erythropoiesis and hemolysis resulting in anemia. Circulating erythroblasts and erythroblasts in the bone marrow show various morphologic abnormalities. Affected individuals with CDA4 also have increased levels of fetal hemoglobin.
  • Sequence similarities

    Belongs to the krueppel C2H2-type zinc-finger protein family.
    Contains 3 C2H2-type zinc fingers.
  • Post-translational

    Acetylated; can be acetylated on both Lys-274 and Lys-288. Acetylation on Lys-274 (by CBP) appears to be the major site affecting EKLF transactivation activity.
    Sumoylated; sumoylation, promoted by PIAS1, leads to repression of megakaryocyte differentiation. Also promotes the interaction with the CDH4 subunit of the NuRD repression complex.
    Phosphorylated primarily on serine residues in the transactivation domain. Phosphorylation on Thr-23 is critical for the transactivation activity.
  • Cellular localization

    Nucleus. Colocalizes with SUMO1 in nuclear speckles.
  • Information by UniProt
  • Database links

  • Alternative names

    • CDAN4 antibody
    • EKLF antibody
    • EKLF PEN antibody
    • Erythroid krueppel like transcription factor (EKLF) (Erythroid transcription factor) antibody
    • Erythroid krueppel-like transcription factor antibody
    • Erythroid Kruppel like factor antibody
    • Erythroid specific transcription factor EKLF antibody
    • HBFQTL6 antibody
    • Human erythroid-specific transcription factor EKLF mRNA complete cds antibody
    • INLU antibody
    • Klf1 antibody
    • KLF1_HUMAN antibody
    • Krueppel-like factor 1 antibody
    • Kruppel like factor 1 (erythroid) antibody
    see all


  • Detection of EKLF / KLF1 binding at the region upstream of the transcription start site of the HBE1 gene by ChIP with ab2483. Chromatin from CD43+ cells was cross-linked prior to ChIP using ab2483 at a concentration of 0.2 µg/µg chromatin. DNA was quantified using RT-PCR. Please see abreview by Genpathway Inc for additional details.


This product has been referenced in:

  • Chennupati V  et al. Ribonuclease inhibitor 1 regulates erythropoiesis by controlling GATA1 translation. J Clin Invest 128:1597-1614 (2018). Read more (PubMed: 29408805) »
  • Li Y  et al. MicroRNA 200a inhibits erythroid differentiation by targeting PDCD4 and THRB. Br J Haematol 176:50-64 (2017). Read more (PubMed: 27734462) »
See all 11 Publications for this product

Customer reviews and Q&As

1-2 of 2 Abreviews or Q&A


Thank you for contacting Abcam.

I have looked in this and it appears that the wrong image was placed on the Webpage for ab2483, however we do guarantee the antibody to work in ChIP, as the correct image can be found at the link below:


Also we have 2 publications that have successfully used this antibody in ChIP:


I am sorry about this confusion and I will have it sorted as soon as possible but you can be confident that the antibody is covered under our Abpromise to work in ChiP.

If there is anything else I can help you with, please let me know.

Read More
Detection step
Real-time PCR
Human Cell lysate - nuclear (CD34+ cells)
CD34+ cells
Negative control
Region on chromosome 5 (Untr5) that is far from any known gene annotation and not expected to be bound by KLF1
Cross-linking (X-ChIP)
Duration of cross-linking step: 15 minute(s) and 0 second(s)
Specification of the cross-linking agent: Formaldehyde
Positive control
Region upstream of the transcription start site of the HBE1 gene

Mr. Genpathway Inc

Verified customer

Submitted Jul 29 2009

For licensing inquiries, please contact partnerships@abcam.com

Sign up